Which is the best empirical treatment in patients with urethritis?;¿Qué tratamiento empírico es el más adecuado en pacientes con uretritis?

Revista Espanola de Quimioterapia

Volumn 24, Issue 3, 2011, Pages 136-142

  Miguel, Ma Ángeles Orellana ^a   Centelles, Ma Luisa Gómez Lus ^b  

^a Centro de Especialidades Pontones   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Antimicrobial resistance; Empirical treatment; N.gonorrhoeae; Primary assistance; Urethritis

Indexed keywords

AMOXICILLIN; AMPICILLIN; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; CLAVULANIC ACID; COTRIMOXAZOLE; DOXYCYCLINE; PENICILLIN G; TETRACYCLINE;

ARTICLE; CHLAMYDIA TRACHOMATIS; EMPIRICISM; HERPES SIMPLEX; HUMAN; MALE; MICROORGANISM; MYCOPLASMA HOMINIS; NEISSERIA GONORRHOEAE; TRICHOMONAS VAGINALIS; UREAPLASMA UREALYTICUM; URETHRITIS;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; ANTIVIRAL AGENTS; BACTERIA; DRUG RESISTANCE, BACTERIAL; EXUDATES AND TRANSUDATES; FEMALE; GONORRHEA; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; SPAIN; URETHRITIS; YOUNG ADULT;

EID: 80054779139     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. o VIII. Enfermedades de Transmisión Sexual. (www.seimc.org).
2. Cacho J, Sanz F, Blanco MA y Grupo de ETS - Perinatal de SMMC. La enfermedad silenciosa por Chlamydia trachomatis: necesidad urgente de detección y tratamiento en mujeres. Enferm Infecc Microbiol Clin 2001; 19: 419-21.
3. Orellana MA, Gomez M, Sanchez MT, Fernandez-Chacon T. Diagnosis of urethritis in men. A 3-year review. Rev Esp Quimioter 2009; 22: 83-7.
4. Arreaza L, Vazquez F, Alcala B, Otero L, Salcedo C, Vazquez JA. Emergence of gonococcal strains with resistance to azithromycin in Spain. J Antimicrob Chemother 2003; 51: 190-1.
5. Murray PR, Rosenthal KS, Pfaller MA. Neisseria y grupos relacionados. Microbiología Médica. 5a edición. Madrid. ELSEVIER MOSBY; 2006. p. 311-21.
6. Vazquez F, Otero L, Ordas J, Junquera ML, Varela JA. Actualización en infecciones de transmisión sexual: epidemiología, diagnóstico y tratamiento. Enferm Infecc Microbiol Clin 2004; 22: 392-411.
7. Otero L, Alcala B, Varela JA, Miguel MD, Vazquez JA, Vazquez F. First isolate of a Neisseria gonorrhoeae strain associated with an ofloxacin treatment failure in Spain: case report. Sex Transm Dis 2001; 28: 576-8.
8. Alcala B, Arreaza L, Salcedo C, Antolin I, Borrell N, Cacho J, et al. Molecular characterization of ciprofloxacin resistance of gonococcal strains in Spain. Sex Transm Dis 2003; 30: 395-8.
9. Centers for Disease Control and Prevention. Sexually Transmitted Diseases Surveillance 2005. 2006: 139-50.
10. o 1.
11. a edición Buenos Aires; Madrid; Panamericana; 2005. p. 556-65.
12. Robinson AJ, Ridgway GL. Concurrent gonococcal and chlamydial infection: how best to treat. Drugs 2000; 59: 801-13.
13. Nusbaum MR, Wallace RR, Slatt LM, Kondrad EC. Sexually transmitted infections and increased risk of co-infection with human immunodeficiency virus. J Am Osteopath Assoc 2004; 104: 527-35.
14. Harindra V, Tobin JM, Underhill G. Opportunistic chlamydia screening; should positive patients be screened for co-infections? Int J STD AIDS 2002; 13: 821-5.
15. Perea EJ, Garcia-Lopez JL, Martin R, Calmet M, Cisterna R, Estebanez V, et al. Antimicrobial sensitivity of 402 strains of Neisseria gonorrhoeae isolated in 7 Spanish cities. Enferm Infecc Microbiol Clin 1991; 9: 619-23.
16. Berron S, Vazquez JA, Gimenez MJ, de la Fuente L, Aguilar L. In vitro susceptibilities of 400 Spanish isolates of Neisseria gonorrhoeae to gemifloxacin and 11 other antimicrobial agents. Antimicrob Agents Chemother 2000; 44: 2543-4.
17. Kobayashi I, Kanayama A, Saika T, Nishida M, Nakayama H, Tanaka M, et al. Tendency toward increase in the frequency of isolation of beta-lactamase-nonproducing Neisseria gonorrhoeae exhibiting penicillin resistance, and recent emergence of multidrug-resistant isolates in Japan. J Infect Chemother 2003; 9: 126-30.
18. Arreaza L, Salcedo C, Alcala B, Berron S, Martin E, Vazquez JA. Antibiotic resistance of Neisseria gonorrhoeae in Spain: trends over the last two decades. J Antimicrob Chemother 2003; 51: 153-6.
19. Wang SA, Harvey AB, Conner SM, Zaidi AA, Knapp JS, Whittington WL, et al. Antimicrobial resistance for Neisseria gonorrhoeae in the United States, 1988 to 2003: the spread of fluoroquinolone resistance. Ann Intern Med 2007; 147: 81-8.
20. Australian Gonococcal Surveillance Programme. Annual report of the Australian Gonococcal Surveillance Programme, 2007. Commun Dis Intell 2008; 32: 227-31.
21. Martin IM, Hoffmann S, Ison CA, ESSTI Network. European Surveillance of Sexually Transmitted Infections (ESSTI): the first combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe. J Antimicrob Chemother 2006; 58: 587-93.
22. Bala M, Ray K, Gupta SM, Muralidhar S, Jain RK. Changing trends of antimicrobial susceptibility patterns of Neisseria gonorrhoeae in India and the emergence of ceftriaxone less susceptible N. gonorrhoeae strains. J Antimicrob Chemother 2007; 60: 582-6.
23. Tanaka M, Nakayama H, Huruya K, Konomi I, Irie S, Kanayama A, et al. Analysis of mutations within multiple genes associated with resistance in a clinical isolate of Neisseria gonorrhoeae with reduced ceftriaxone susceptibility that shows a multidrug-resistant phenotype. Int J Antimicrob Agents 2006; 27: 20-6.
24. Centers for Disease Control and Prevention, Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006; 55(RR-11): 1-94.
25. Ota KV, Jamieson F, Fisman DN, Jones KE, Tamari IE, Ng LK, et al. Prevalence of and risk factors for quinolone-resistant Neisseria gonorrhoeae infection in Ontario. CMAJ 2009; 180: 287-90.
26. Vazquez F, Andres MT, Palacio V, Vazquez S, de Lillo A, Fierro JF. Isolation of Haemophilus influenzae and Haemophilus parainfluenzae in genitourinary infections: a 4-year review. Enferm Infecc Microbiol Clin 1996; 14: 181-5.
27. Perea EJ, Garcia MC, Clavijo MJ, Piedrola G, Campos J, Garcia-Rodriguez JA, et al. Resistance in Haemophilus influenzae in Spain. 2d study (1990). Enferm Infecc Microbiol Clin 1993; 11: 19-28.
28. Canós M, Gobernado M. Resistencia de Haemophilus sp a la ampicilina: un problema en contínuo crecimiento. Rev Esp Quimioter 1994; 7: 274-8.
29. Garcia-Cobos S, Campos J, Cercenado E, Roman F, Lazaro E, Perez-Vazquez M, et al. Antibiotic resistance in Haemophilus influenzae decreased, except for beta-lactamase-negative amoxicillin-resistant isolates, in parallel with community antibiotic consumption in Spain from 1997 to 2007. Antimicrob Agents Chemother 2008; 52: 2760-6.
30. Seral C, Suarez L, Rubio-Calvo C, Gomez-Lus R, Gimeno M, Coronel P, et al. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain. Diagn Microbiol Infect Dis 2008; 62: 210-5.
31. Garcia-Cobos S, Campos J, Lazaro E, Roman F, Cercenado E, Garcia- Rey C, et al. Ampicillin-resistant non-beta-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime. Antimicrob Agents Chemother 2007; 51: 2564-73.
32. Kechagia N, Bersimis S, Chatzipanagiotou S. Incidence and antimicrobial susceptibilities of genital mycoplasmas in outpatient women with clinical vaginitis in Athens, Greece. J Antimicrob Chemother 2008; 62: 122-5.
33. Karabay O, Topcuoglu A, Kocoglu E, Gurel S, Gurel H, Ince NK. Prevalence and antibiotic susceptibility of genital Mycoplasma hominis and Ureaplasma urealyticum in a university hospital in Turkey. Clin Exp Obstet Gynecol 2006; 33: 36-8.
34. Kilic D, Basar MM, Kaygusuz S, Yilmaz E, Basar H, Batislam E. Prevalence and treatment of Chlamydia trachomatis, Ureaplasma urealyticum, and Mycoplasma hominis in patients with non-gonococcal urethritis. Jpn J Infect Dis 2004; 57: 17-20.